Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency

1 May 1999

Abstract excerpt

We determined the aneuploidy detection rate achievable by early pregnancy screening with pregnancy associated plasma protein (PAPP)-A, free beta human chorionic gonadotrophin (hCG) and ultrasound nuchal translucency (NT) measurement. Women having prenatal diagnosis were scanned, and a blood sample was taken and stored. Stored samples were tested and a total of 37 were found to have Down syndrome, 8 to have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics
Share to Tumors and Oncological Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10360515
DOI: 10.1002/(sici)1097-0223(199905)19:5<458::aid-pd569>3.0.co;2-a

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucencyPMID 10360515Read ↗

First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucencySemantic proximity Read ↗

Appropriate biochemical parameters in first-trimester screening for Down syndromeSemantic proximity Read ↗

First‐trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practiceSemantic proximity Read ↗

ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal AbnormalitiesSemantic proximity Read ↗

First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucencySemantic proximity Read ↗

Improved first‐trimester Down syndrome screening performance by lowering the false‐positive rate: a prospective study of 9941 low‐risk womenSemantic proximity Read ↗

Maternal serum pregnancy‐associated plasma protein a and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancySemantic proximity Read ↗

Integrated first‐ and second‐trimester Down syndrome screening test among unaffected IVF pregnanciesSemantic proximity Read ↗

First trimester screening for aneuploidy: Serum biochemical markersSemantic proximity Read ↗

Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysisSemantic proximity Read ↗

Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β -hCG and PAPP-A at 10-14 weeks of gestationSemantic proximity Read ↗

Ultrasonographic fetal soft markers in a low‐risk population: prevalence, association with trisomies and invasive testsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.